Margus Viigimaa
0000-0001-5575-5978
Publication & Citation Trends
Publications
0 total
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Cited by 1
Semantic Scholar
Stroke Action Plan for Europe 2018–2030 (SAP-E): mid-term review and update
Cited by 1
Semantic Scholar
Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial
Cited by 0
Semantic Scholar
The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!
Cited by 1
Semantic Scholar
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Cited by 1
Semantic Scholar
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).
Cited by 2
Semantic Scholar
Vascular calcification inhibitors in chronic kidney disease.
Cited by 1
Semantic Scholar
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES.
Cited by 11
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(54)
Blood Pressure and Hypertension Studies
(49)
Cardiovascular Health and Disease Prevention
(33)
Non-Invasive Vital Sign Monitoring
(24)
Health Systems, Economic Evaluations, Quality of Life
(18)
Affiliations
Délégation Paris 5
Tallinn University of Technology
Uppsala University
Oslo University Hospital
Institute of the Estonian Language